Testing effectiveness (Phase 2)UnknownNCT02803840What this trial is testingLow-dose Radiotherapy for Diffuse Large B-cell LymphomaWho this might be right forLymphoma Centro di Riferimento Oncologico - Aviano 25
Early research (Phase 1)Looking for participantsNCT06708897What this trial is testingLonitoclax (ZE50-0134) in Relapsed or Refractory B-cell MalignanciesWho this might be right forCLL / SLLCLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)+2 more Lomond Therapeutics Holdings, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT00040846What this trial is testingAlemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT00188461What this trial is testingDose Reduction in Thoracic CTWho this might be right forLymphoma University Health Network, Toronto 100
Testing effectiveness (Phase 2)Study completedNCT02061761What this trial is testingEvaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell MalignanciesWho this might be right forHematologic Neoplasms Bristol-Myers Squibb 106
Not applicableLooking for participantsNCT06727942What this trial is testingVirtual Reality-Infused Treadmill Training on Aging-Related OutcomesWho this might be right forAdult ALL The University of Texas at Arlington 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04246086What this trial is testingA Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular LymphomaWho this might be right forFollicular Lymphoma Hoffmann-La Roche 237
Not applicableUnknownNCT00266370What this trial is testingA Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant LymphomaWho this might be right forLymphoma National Health Research Institutes, Taiwan 100
Not applicableUnknownNCT01953770What this trial is testingChildhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008Who this might be right forChildhood Acute Lymphoblastic Leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology 3,000
Not applicableUnknownNCT04916860What this trial is testingClinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaWho this might be right forSenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Hebei Senlang Biotechnology Inc., Ltd. 100
Not applicableUnknownNCT02808520What this trial is testingSocial Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphomaWho this might be right forClassical Hodgkin Lymphoma Martin-Luther-Universität Halle-Wittenberg 700
Early research (Phase 1)Study completedNCT00374179What this trial is testingCT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's LymphomaWho this might be right forCancer Adnexus, A Bristol-Myers Squibb R&D Company 40
Testing effectiveness (Phase 2)Ended earlyNCT00901927What this trial is testingBendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular LymphomaWho this might be right forFollicular Lymphoma M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07753642What this trial is testingGolidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell LymphomaWho this might be right forNodal T-follicular Helper Cell Lymphoma Sun Yat-sen University 47
Early research (Phase 1)Looking for participantsNCT07586618What this trial is testingFirst-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.Who this might be right forLymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL Allterum Therapeutics, Inc 24
Very early researchLooking for participantsNCT07548697What this trial is testingA Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin LymphomaWho this might be right forB-cell Non Hodgkin Lymphoma (NHL)DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma (FL) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Study completedNCT03610724What this trial is testingPhase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma PatientsWho this might be right forNon-Hodgkin Lymphoma Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Looking for participantsNCT06569680What this trial is testingMosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone LymphomaWho this might be right forExtranodal Marginal Zone Lymphoma Izidore Lossos, MD 35
Early research (Phase 1)Study completedNCT02323880What this trial is testingSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasWho this might be right forMalignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more Children's Oncology Group 59
Early research (Phase 1)Study completedNCT00058396What this trial is testingMonoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center